IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HODGKIN LYMPHOMA PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO‐SCT) WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE (PT‐CY).

Authors :: Castagna, L.
Bramanti, S.
Devillier, R.
Pagliardini, T.
Sarina, B.
Lemarie, C.
Furst, S.
Mariotti, J.
Granata, A.
Philippis, C.
Harbi, S.
Legrand, F.
Maisano, V.
Bouabdallah, R.
Carlo‐Stella, C.
Calmels, B.
Chabannon, C.
Blaise, D.
Santoro, A.
Source :: Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p300-301, 2p
Publication Year :: 2019

Subjects :: STEM cell transplantation
HODGKIN'S disease
FLUDARABINE
GRAFT versus host disease
HISTOCOMPATIBILITY class I antigens

Full Text Access

Tools